Michael D. Clayman

Chief Executive Officer, Flexion Therapeutics.

Companies

Flexion TherapeuticsBoard member Feb 11, 2014 to Nov 19, 2021¹
Flexion TherapeuticsChief executive officer Feb 11, 2014 to Nov 19, 2021¹
Flexion TherapeuticsPresident Feb 11, 2014 to Nov 19, 2021¹
Akebia Therapeutics, Inc.Board member Aug 1, 2014 to Jun 15, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Flexion Therapeutics0 shares³Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 19, 2021Returned to company 388,683 shares at $8.50 of Flexion Therapeutics³
Nov 19, 2021Returned to company 24,600 shares at $8.50 of Flexion Therapeutics³
Nov 19, 2021Returned to company 373,769 shares at $8.50 of Flexion Therapeutics³
Nov 19, 2021Returned to company 335,498 shares at $8.50 of Flexion Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFlexion Therapeutics, Board member
2
SEC EDGARAkebia Therapeutics, Inc., Board member
3
SEC EDGARFlexion Therapeutics shares after the filing of Nov 19, 2021